A. Jemal, R. , E. Ward, Y. Hao, J. Xu et al., Cancer Statistics, 2008, CA: A Cancer Journal for Clinicians, vol.58, issue.2, pp.71-96, 2008.
DOI : 10.3322/CA.2007.0010

S. Marur and A. Forastiere, Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment, Mayo Clinic Proceedings, vol.83, issue.4, pp.489-501, 2008.
DOI : 10.4065/83.4.489

M. Spitz, Epidemiology and risk factors for head and neck cancer, Semin Oncol, vol.21, pp.281-288, 1994.

A. Forastiere, W. Koch, A. Trotti, and D. Sidransky, Head and Neck Cancer, New England Journal of Medicine, vol.345, issue.26, pp.1890-1900, 2001.
DOI : 10.1056/NEJMra001375

A. Jemal, T. Murray, E. Ward, A. Samuels, and R. Tiwari, Cancer Statistics, 2005, Cancer statistics, pp.10-30, 2005.
DOI : 10.3322/canjclin.55.1.10

V. Patel, C. Leethanakul, and J. Gutkind, New Approaches To the Understanding of the Molecular Basis of Oral Cancer, Critical Reviews in Oral Biology & Medicine, vol.12, issue.1, pp.55-63, 2001.
DOI : 10.1177/10454411010120010401

P. Friedlander, The Use of Genetic Markers in the Clinical Care of Patients With Head and Neck Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.129, issue.3, pp.363-366, 2003.
DOI : 10.1001/archotol.129.3.363

J. Rodrigo, C. Suarez, A. Ferlito, K. Devaney, and G. Petruzzelli, Potential Molecular Prognostic Markers for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma, Acta Oto-Laryngologica, vol.128, issue.1, pp.100-105, 2003.
DOI : 10.1080/0036554021000028073

H. Schliephake, Prognostic relevance of molecular markers of oral cancer???A review, International Journal of Oral and Maxillofacial Surgery, vol.32, issue.3, pp.233-245, 2003.
DOI : 10.1054/ijom.2002.0383

S. Chang and J. Califano, Current status of biomarkers in head and neck cancer, Journal of Surgical Oncology, vol.10, issue.8, pp.640-643, 2008.
DOI : 10.1002/jso.21023

D. Avram, A. Fields, K. Pretty-on-top, D. Nevrivy, and J. Ishmael, Isolation of a Novel Family of C2H2 Zinc Finger Proteins Implicated in Transcriptional Repression Mediated by Chicken Ovalbumin Upstream Promoter Transcription Factor (COUP-TF) Orphan Nuclear Receptors, Journal of Biological Chemistry, vol.275, issue.14, pp.10315-10322, 2000.
DOI : 10.1074/jbc.275.14.10315

D. Avram, A. Fields, T. Senawong, A. Topark-ngarm, and M. Leid, COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein, Biochemical Journal, vol.368, issue.2, pp.555-563, 2002.
DOI : 10.1042/bj20020496

V. Cismasiu, K. Adamo, J. Gecewicz, J. Duque, and Q. Lin, BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter, Oncogene, vol.983, issue.45, pp.6753-6764, 2005.
DOI : 10.1101/GAD.13.18.2388

A. Topark-ngarm, O. Golonzhka, V. Peterson, B. Barrett, . Jr et al., CTIP2 Associates with the NuRD Complex on the Promoter of p57KIP2, a Newly Identified CTIP2 Target Gene, Journal of Biological Chemistry, vol.281, issue.43, pp.32272-32283, 2006.
DOI : 10.1074/jbc.M602776200

Y. Wakabayashi, H. Watanabe, J. Inoue, N. Takeda, and J. Sakata, Bcl11b is required for differentiation and survival of ???? T lymphocytes, Nature Immunology, vol.4, issue.6, pp.533-539, 2003.
DOI : 10.1038/ni927

T. Senawong, V. Peterson, and M. Leid, BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression, Archives of Biochemistry and Biophysics, vol.434, issue.2, pp.316-325, 2005.
DOI : 10.1016/j.abb.2004.10.028

G. Przybylski, W. Dik, J. Wanzeck, P. Grabarczyk, and S. Majunke, Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL, Leukemia, vol.19, issue.2, pp.201-208, 2005.
DOI : 10.1038/sj.leu.2403619

E. Satterwhite, T. Sonoki, T. Willis, L. Harder, and R. Nowak, The BCL11 gene family: involvement of BCL11A in lymphoid malignancies, Blood, vol.98, issue.12, pp.3413-3420, 2001.
DOI : 10.1182/blood.V98.12.3413

O. Golonzhka, M. Leid, G. Indra, and A. Indra, Expression of COUP-TF-interacting protein 2 (CTIP2) in mouse skin during development and in adulthood, Gene Expression Patterns, vol.7, issue.7, pp.754-760, 2007.
DOI : 10.1016/j.modgep.2007.06.002

M. Leid, J. Ishmael, A. D. Shepherd, D. Fraulob, and V. , CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis, Gene Expression Patterns, vol.4, issue.6, pp.733-739, 2004.
DOI : 10.1016/j.modgep.2004.03.009
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819357

O. Golonzhka, X. Liang, N. Messaddeq, J. Bornert, and A. Campbell, Dual Role of COUP-TF-Interacting Protein 2 in Epidermal Homeostasis and Permeability Barrier Formation, Journal of Investigative Dermatology, vol.129, issue.6, 2008.
DOI : 10.1038/jid.2008.392
URL : https://hal.archives-ouvertes.fr/inserm-00387992

H. Dvorak, Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing, N Engl J Med, vol.315, pp.1650-1659, 1986.

A. Seghatoleslam, A. Zambrano, R. Millon, G. Ganguli, and M. Argentini, Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours, Biochemical and Biophysical Research Communications, vol.339, issue.1, pp.422-429, 2006.
DOI : 10.1016/j.bbrc.2005.11.026
URL : https://hal.archives-ouvertes.fr/hal-00188137

A. Indra, W. Mohan, M. Frontini, E. Scheer, and N. Messaddeq, TAF10 is required for the establishment of skin barrier function in foetal, but not in adult mouse epidermis, Developmental Biology, vol.285, issue.1, pp.28-37, 2005.
DOI : 10.1016/j.ydbio.2005.05.043
URL : https://hal.archives-ouvertes.fr/hal-00187633

K. Nowak, K. Kerl, D. Fehr, C. Kramps, and C. Gessner, BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas, Nucleic Acids Research, vol.34, issue.6, pp.1745-1754, 2006.
DOI : 10.1093/nar/gkl119

Y. Li, S. John, M. Zhou, X. Kim, Y. Sinha et al., Salivary Transcriptome Diagnostics for Oral Cancer Detection, Clinical Cancer Research, vol.10, issue.24, pp.8442-8450, 2004.
DOI : 10.1158/1078-0432.CCR-04-1167

J. Lessard and G. Sauvageau, Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells, Nature, vol.2, issue.6937, pp.255-260, 2003.
DOI : 10.1038/sj.onc.1201883

A. Molofsky, R. Pardal, T. Iwashita, I. Park, and M. Clarke, Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation, Nature, vol.425, issue.6961, pp.962-967, 2003.
DOI : 10.1038/nature02060

I. Park, D. Qian, M. Kiel, M. Becker, and M. Pihalja, Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells, Nature, vol.90, issue.6937, pp.302-305, 2003.
DOI : 10.1084/jem.20011911

T. Chiba, S. Miyagi, A. Saraya, R. Aoki, and A. Seki, The Polycomb Gene Product BMI1 Contributes to the Maintenance of Tumor-Initiating Side Population Cells in Hepatocellular Carcinoma, Cancer Research, vol.68, issue.19, pp.7742-7749, 2008.
DOI : 10.1158/0008-5472.CAN-07-5882

J. Dovey, S. Zacharek, C. Kim, and J. Lees, Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion, Proceedings of the National Academy of Sciences, vol.105, issue.33, pp.11857-11862, 2008.
DOI : 10.1073/pnas.0803574105

G. Glinsky, ???Stemness??? Genomics Law Governs Clinical Behavior of Human Cancer: Implications for Decision Making in Disease Management, Journal of Clinical Oncology, vol.26, issue.17, pp.2846-2853, 2008.
DOI : 10.1200/JCO.2008.17.0266

J. Godlewski, M. Nowicki, A. Bronisz, S. Williams, and A. Otsuki, Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal, Cancer Research, vol.68, issue.22, pp.9125-9130, 2008.
DOI : 10.1158/0008-5472.CAN-08-2629

B. Mack and O. Gires, CD44s and CD44v6 Expression in Head and Neck Epithelia, PLoS ONE, vol.97, issue.10, p.3360, 2008.
DOI : 10.1371/journal.pone.0003360.s002

A. Pietersen, B. Evers, A. Prasad, E. Tanger, and P. Cornelissen-steijger, Bmi1 Regulates Stem Cells and Proliferation and Differentiation of Committed Cells in Mammary Epithelium, Current Biology, vol.18, issue.14, pp.1094-1099, 2008.
DOI : 10.1016/j.cub.2008.06.070

M. Prince and L. Ailles, Cancer Stem Cells in Head and Neck Squamous Cell Cancer, Journal of Clinical Oncology, vol.26, issue.17, pp.2871-2875, 2008.
DOI : 10.1200/JCO.2007.15.1613

M. Prince, R. Sivanandan, A. Kaczorowski, G. Wolf, and M. Kaplan, Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma, Proceedings of the National Academy of Sciences, vol.104, issue.3, pp.973-978, 2007.
DOI : 10.1073/pnas.0610117104

G. Ganguli-indra, X. Liang, S. Hyter, M. Leid, and J. Hanifin, Expression of COUP-TF-interacting protein 2 (CTIP2) in human atopic dermatitis and allergic contact dermatitis skin, Experimental Dermatology, vol.182, issue.11, 2009.
DOI : 10.1111/j.1600-0625.2009.00876.x

H. Korkaya and M. Wicha, Selective Targeting of Cancer Stem Cells, BioDrugs, vol.64, issue.12, pp.299-310, 2007.
DOI : 10.2165/00063030-200721050-00002

R. Macleod, S. Nagel, and H. Drexler, BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia, Cancer Genetics and Cytogenetics, vol.153, issue.1, pp.88-89, 2004.
DOI : 10.1016/j.cancergencyto.2004.02.020

K. Kamimura, Y. Mishima, M. Obata, T. Endo, and Y. Aoyagi, Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages, Oncogene, vol.300, issue.40, pp.5840-5850, 2007.
DOI : 10.1038/sj.onc.1210388

S. Lu, H. Herrington, and X. Wang, Mouse models for human head and neck squamous cell carcinomas, Head & Neck, vol.2, issue.10, pp.945-954, 2006.
DOI : 10.1002/hed.20397